Natera, Inc. (NTRA) — Stock Score Summary

Natera, Inc. (NTRA) has a MoatMap StockRank of 57/100 based on Quality (55/100), Value (33/100), and Momentum (53/100) factor scores. The current signal is HOLD. Natera operates in the specialized diagnostics space, which can benefit from Moated Pricing Power through proprietary technology and switching costs. There's a potential long-term runway for genomics-driven healthcare, aligning with the quality theme.

Natera, Inc. is a leading diagnostic company focused on cell-free DNA testing for reproductive health, oncology, and organ transplantation. The company's proprietary technology platforms, including Panorama for non-invasive prenatal testing and Signatera for molecular residual disease detection, establish a significant competitive moat in precision medicine. Its commitment to R&D and clinical validation drives its rapid growth and market leadership in targeted diagnostic areas.

Key Financial Metrics

Price$207.56
Market Cap$29.8B
P/E (Forward)-518.46
Price/Book15.99
Return on Equity-15.0%
Return on Invested Capital-13.5%
Debt/Equity13.53
Gross Margin65.1%
Operating Margin-12.4%
Revenue Growth38.8%
Free Cash Flow$137M

Natera, Inc. operates in the Diagnostics & Research industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Natera, Inc.’s (NTRA) StockRank?
MoatMap’s StockRank for Natera, Inc. (NTRA) is 57/100, with a Hold signal. It is a composite of Quality (55), Value (33), and Momentum (53) factor ranks across MoatMap’s 15,000+ stock universe.
Does Natera, Inc. have an economic moat?
Natera, Inc. (NTRA) has a Quality factor score of 55/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Natera, Inc. a buy, hold, or sell?
MoatMap’s current signal for Natera, Inc. (NTRA) is Hold, based on a StockRank of 57/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Natera, Inc. in?
Natera, Inc. (NTRA) operates in the Healthcare sector, specifically the Diagnostics & Research industry (United States).
Browse all ranked stocksNTRA deep dive reportAI ChampionsHow we score stocksSense-check another stock